191
Participants
Start Date
November 8, 2022
Primary Completion Date
July 2, 2024
Study Completion Date
August 27, 2024
XXB750 drug
SC injection
Placebo
SC injection
Novartis Investigative Site, Taipei
Novartis Investigative Site, Vienna
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Adelaide
Novartis Investigative Site, Pleven
Novartis Investigative Site, Perth
Novartis Investigative Site, Graz
Novartis Investigative Site, Taipei
Novartis Investigative Site, Berlin
Novartis Investigative Site, Taipei
Novartis Investigative Site, Prague
Manassas Clinical Research Center, Manassas
Novartis Investigative Site, Milan
Novartis Investigative Site, Milan
Capitol Cardiology Associates, Lanham
Anderson Medical Research, Ft. Washington
MD Medical Research, Oxon Hill
Dominion Medical Associates, Richmond
Novartis Investigative Site, Brescia
Novartis Investigative Site, Madrid
The Research Center of the Upstate, Greenville
American Clinical Trials, Acworth
Novartis Investigative Site, Pamplona
Jacksonville Center for Clinical Research, Jacksonville
Inpatient Research Clinical LLC, Miami Lakes
Novartis Investigative Site, Taoyuan District
Cardiology Partners Clinical Research Institute, Wellington
Canvas Clinical Research, Lake Worth
Parkway Medical Center, Birmingham
Pinnacle Research Group Llc, Anniston
Novartis Investigative Site, Tours
Tennessee Center For Clinical Trials, Tullahoma
Novartis Investigative Site, Bologna
Novartis Investigative Site, Seville
NexGen Research, Lima
Novartis Investigative Site, Valencia
Novartis Investigative Site, Pisa
Novartis Investigative Site, Lille
Novartis Investigative Site, Frankfurt am Main
Alliance for Multispecialty Resrch, Wichita
Novartis Investigative Site, Paris
Novartis Investigative Site, Ulm
Novartis Investigative Site, Erlangen
Orange County Research Center, Tustin
Novartis Investigative Site, Bobigny
Novartis Investigative Site, Beijing
Novartis Investigative Site, Shanghai
Novartis Investigative Site, Qingdao
Novartis Investigative Site, Guangzhou
Clinical Trials Research Sacramento, Sacramento
Novartis Investigative Site, Baotou
Novartis Investigative Site, Brandýs nad Labem
Novartis Investigative Site, Elsterwerda
Novartis Investigative Site, Chikushino-shi
Novartis Investigative Site, Kanazawa
Novartis Investigative Site, Yokohama
Novartis Investigative Site, Yokosuka
Novartis Investigative Site, Kishiwada
Novartis Investigative Site, Chuo Ku
Novartis Investigative Site, Chuo-ku
Novartis Investigative Site, Chuo Ku
Novartis Investigative Site, Amsterdam
Novartis Investigative Site, Gdynia
Novartis Investigative Site, Katowice
Novartis Investigative Site, Krakow
Novartis Investigative Site, Wroclaw
Novartis Investigative Site, Bardejov
Novartis Investigative Site, Košice
Novartis Investigative Site, Nitra
Novartis Investigative Site, Svidník
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Terrassa
Novartis Investigative Site, Barcelona
Novartis Investigative Site, London
Novartis Investigative Site, London
Novartis Investigative Site, Salford
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY